{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:18:47Z","timestamp":1775474327891,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.594900","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T06:27:05Z","timestamp":1605248825000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR"],"prefix":"10.3389","volume":"7","author":[{"given":"Margalida","family":"Esteva-Socias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Enver-Sumaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"G\u00f3mez-Bellvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aitor","family":"Azk\u00e1rate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Mars\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00darsula","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Calabuig-Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor Jos\u00e9","family":"Asensio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefa","family":"Terrasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f2nia","family":"Obrador-Hevia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"Ferlay","year":"2007","journal-title":"Ann Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"CRA7506","DOI":"10.1200\/jco.2011.29.15_suppl.cra7506","article-title":"Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: the NCI's Lung Cancer Mutation Consortium (LCMC)","volume":"29","author":"Kris","year":"2011","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung, cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science."},{"key":"B6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ijc.21496","article-title":"Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers","volume":"118","author":"Shigematsu","year":"2006","journal-title":"Int J Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/onc.2012.21","article-title":"Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor","volume":"32","author":"Yoshikawa","year":"2013","journal-title":"Oncogene."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.1158\/0008-5472.CAN-06-0453","article-title":"Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib","volume":"66","author":"Carey","year":"2006","journal-title":"Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1126\/science.1101637","article-title":"Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways","volume":"305","author":"Sordella","year":"2004","journal-title":"Science."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1158\/0008-5472.CAN-05-1346","article-title":"An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor","volume":"65","author":"Kobayashi","year":"2005","journal-title":"Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1256930","article-title":"Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing","volume":"346","author":"Zhang","year":"2014","journal-title":"Science."},{"key":"B14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3892\/ol.2017.7428","article-title":"Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival","volume":"15","author":"Shen","year":"2018","journal-title":"Oncol Lett."},{"key":"B17","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2008","journal-title":"Clin Biochem Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41419-019-1770-3","article-title":"Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study","volume":"10","author":"Alborelli","year":"2019","journal-title":"Cell Death Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1158\/1078-0432.CCR-13-2482","article-title":"Noninvasive detection of response and resistance in Egfrmutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA","volume":"20","author":"Oxnard","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jmoldx.2015.01.004","article-title":"Highly sensitive droplet digital PCR method for detection of EGFR-activating mutations in plasma cell-free DNA from patients with advanced non-small cell lung cancer","volume":"17","author":"Zhu","year":"2015","journal-title":"J Mol Diagn."},{"key":"B21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12885-017-3424-0","article-title":"Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients","volume":"17","author":"van Ginkel","year":"2017","journal-title":"BMC Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.jmoldx.2020.05.010","article-title":"One-step duplex droplet digital PCR for WT1 overexpression","volume":"22","author":"Dewispelaere","year":"2020","journal-title":"J Mol Diagn."},{"key":"B23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","article-title":"Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies","volume":"14","author":"Volik","year":"2016","journal-title":"Mol Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1471-2407-14-294","article-title":"Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays","volume":"14","author":"Weber","year":"2014","journal-title":"BMC Cancer."},{"key":"B25","unstructured":"The Cobas\u00ae EGFR Mutation Test2019"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1158\/1078-0432.CCR-14-2151","article-title":"Ultra-sensitive detection of the pretreatment EGFR T790M mutation in non-small cell lung cancer patients with an EGFR-activating mutation using droplet digital PCR","volume":"21","author":"Watanabe","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.lungcan.2015.10.004","article-title":"EGFR mutation detection in ctDNA from NSCLC patient plasma: a cross-platform comparison of leading technologies to support the clinical development of AZD9291","volume":"90","author":"Thress","year":"2015","journal-title":"Lung Cancer."},{"key":"B28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41598-017-18642-x","article-title":"Droplet digital PCR-based EGFR mutation detection with an internal quality control index to determine the quality of DNA","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.594900\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T06:27:08Z","timestamp":1605248828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.594900\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":28,"alternative-id":["10.3389\/fmed.2020.594900"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.594900","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"article-number":"594900"}}